Snakebite Science: What We're Learning About Handlers, Venom, and Why First Aid Needs Scrutiny.

Snakebite research has quietly accelerated over the past decade, and the findings are reshaping what we understand about both the danger and the treatment of snake envenoming. Three areas of recent work tell a compelling story: data on Australian snake handlers who get bitten, the intricate chemistry of snake venom, and an emerging concern about a first aid practice that's been standard for over 40 years.

Who Gets Bitten and How

The Australian Snakebite Project (ASP-15) examined 106 professional snake handlers who were bitten on the job. The median age was 40, overwhelmingly male (98 percent), and almost all bites occurred on the upper limbs (97 percent). This matters because it tells us something critical: snake handlers are exposed to risk in a structured, predictable way. They know snakes are dangerous. They expect encounters. Yet they still get bitten.

What's more interesting is what happens after the bite. Among the 60 snake handlers in the dataset, 75 percent experienced no systemic reaction. Only 25 percent showed systemic hypersensitivity reactions (SHSR), and severe anaphylaxis was rare. Compare this to non-snake handlers: only 82 percent had no reaction, with 18 percent developing SHSR and 6 percent experiencing anaphylaxis. The difference is statistically significant and suggests that professional exposure might confer some protective effect, or that handlers are bitten by snakes and in circumstances that differ from the general population.

The snakes involved were the familiar Australian cast: red-bellied black snakes were most common in the handler bites (28 percent), followed by mulga snakes, tiger snakes, and brown snakes. This epidemiology matters because it tells clinicians which species are involved in occupational exposure and what venom profiles they're dealing with.

The Chemistry of Venom

Understanding why venom causes damage requires understanding what's in it. A comprehensive review of snake venom proteomes examined 132 snake species and identified consistent patterns in how snakes evolve their chemical weapons.

Snake venom is dominated by four protein families that do most of the damage. Phospholipase A₂ (PLA₂) breaks down cell membranes. Three-finger toxins are neurotoxins that interfere with nerve signalling. Metalloproteases destroy tissue. Serine proteases disrupt blood clotting. These four families account for roughly 90 percent of venom toxicity across viperine and elapid snakes. Australian elapids like browns, taipans, and tiger snakes rely heavily on these families.

But venom is never simple. A second tier of six protein families adds complexity: natriuretic peptides, C-type lectins, disintegrins, L-amino acid oxidases, cysteine-rich secretory proteins, and kunitz peptides. Although these are present in lower abundance (often under 5 percent of total venom), they're not minor players. Their importance remains poorly understood, which means we're still missing parts of the picture.

The takeaway: snake venom is a precise biochemical system, not a simple poison. Antivenom must neutralise multiple toxin families simultaneously. This is why antivenom specificity matters so much and why a bite from one species cannot be safely treated with antivenom from another.

The Pressure Bandage Problem

Here's where the research turns concerning. For more than 40 years, pressure bandage immobilisation (PBI) has been the recommended first aid for snake bite in Australia. Wrap the limb firmly, immobilise it, and get to hospital. It's logical, teachable, and has been promoted by medical authorities nationwide.

Dr. Mark Little, an emergency physician and clinical toxicologist at Cairns Hospital, has challenged this orthodoxy with case evidence that should alarm anyone involved in snakebite first aid.

He reported two men bitten by snakes who received textbook-perfect pressure bandage immobilisation. One was 35 years old, the other 44. Both were wrapped correctly. Both were then transferred to hospital in remote locations, which meant substantial delays before the bandage could be removed—9.5 hours and 7.5 hours respectively.

What happened next was severe. Both men developed rhabdomyolysis (muscle tissue breakdown), a sign that the venom had caused serious systemic damage. The 35-year-old developed compartment syndrome and required urgent repeated surgery. Two years later, the 44-year-old still has significant foot paralysis.

Little's conclusion is blunt: pressure bandage immobilisation as a first aid measure for snakebite in Australia needs to be re-examined.

This matters because it highlights a gap between theory and practice. A pressure bandage is meant to slow venom distribution into the lymphatic system. But if it works too well—trapping venom in a limb for hours before reaching a hospital—it may concentrate toxic damage in that limb rather than distributing it systemically where antivenom can address it more broadly. The trade-off between local and systemic damage is not well understood.

What It Means

These three research areas converge on a single point: snakebite is more complex than we've treated it. Professional handlers get bitten differently than the general population and seem to fare better, suggesting that knowledge and controlled exposure matter. Venom is a sophisticated multi-toxin system that we're still decoding. And our standard first aid practice may be doing harm in ways we're only now recognising.

For Australia, where snakebite is relatively rare but carries real risk, the research agenda is clear: understand which first aid approaches actually improve outcomes, deepen our knowledge of Australian venom composition, and build better tools for clinicians managing envenoming cases. The science is moving faster than our protocols. It's time protocols caught up.